Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
// Víctor M. Blanco 1 , Zhengtao Chu 1,2 , Subrahmanya D. Vallabhapurapu 1 , Mahaboob K. Sulaiman 1 , Ady Kendler 3 , Olivier Rixe 4 , Ronald E. Warnick 5 , Robert S. Franco 1 and Xiaoyang Qi 1,2 1 Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 2 Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 3 Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 4 Division of Hematology/Oncology, Georgia Regents University, GRU Cancer Center, Augusta, Georgia 5 Department of Neurosurgery, University of Cincinnati Brain Tumor Center, and Mayfield Clinic, Cincinnati, Ohio Correspondence: Xiaoyang Qi, email: // Keywords : Glioblastoma; brain metastasis; SapC-DOPS; imaging; cancer therapy Received : June 2, 2014 Accepted: July 13, 2014 Published: July 14, 2014 Abstract Brain tumors, either primary (e.g., glioblastoma multiforme) or secondary (metastatic), remain among the most intractable and fatal of all cancers. We have shown that nanovesicles consisting of Saposin C (SapC) and dioleylphosphatidylserine (DOPS) are able to effectively target and kill cancer cells both in vitro and in vivo . These actions are a consequence of the affinity of SapC-DOPS for phosphatidylserine, an acidic phospholipid abundantly present in the outer membrane of a variety of tumor cells and tumor-associated vasculature. In this study, we first characterize SapC-DOPS bioavailability and antitumor effects on human glioblastoma xenografts, and confirm SapC-DOPS specificity towards phosphatidylserine by showing that glioblastoma targeting is abrogated after in vivo exposure to lactadherin, which binds phosphatidylserine with high affinity. Second, we demonstrate that SapC-DOPS selectively targets brain metastases-forming cancer cells both in vitro , in co-cultures with human astrocytes, and in vivo , in mouse models of brain metastases derived from human breast or lung cancer cells. Third, we demonstrate that SapC-DOPS nanovesicles have cytotoxic activity against metastatic breast cancer cells in vitro , and prolong the survival of mice harboring brain metastases. Taken together, these results support the potential of SapC-DOPS for the diagnosis and therapy of primary and metastatic brain tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Real-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138
Fitzgerald, D. P., Palmieri, D., Hua, E., Hargrave, E., Herring, J. M., Qian, Y., Vega-Valle, E., Weil, R. J., Stark, A. M., Vortmeyer, A. O., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9193-z · Cited by 218
Cited by
Park, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 382
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98
“A liposomal protein, Saposin C bonded to phosphatidylserine, may be used to fabricate NPs to bind to hypoxic TME [60,61].”
BackgroundDaykin, E. C., Ryan, E., & Sidransky, E. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.01.002 · Cited by 77
“SapC has been coupled with the phospholipid dioleoylphosphatidylserine to create SapC-DOPs nanovesicles that were successfully used to deliver SapC to brain tumors of various origins, demonstrating the CNS selective ability of this approach [139, 140].”
MethodSun, Y., Liou, B., Chu, Z., Fannin, V., Blackwood, R., Peng, Y., Grabowski, G. A., Davis, H. W., & Qi, X. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102735 · Cited by 39
Self-citation
Metadata
- Authors
- Blanco, V. M., Chu, Z., Vallabhapurapu, S. D., Sulaiman, M. K., Kendler, A., Rixe, O., Warnick, R. E., Franco, R. S., & Qi, X.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-07-14
- Volume
- 5
- Issue
- 16
- Pages
- 7105-7118
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1903220464
- Cited by
- 52
- References
- 2
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors. https://app.cochat.ai/papers/10.18632/oncotarget.2214
- The paper
- Blanco, V. M., Chu, Z., Vallabhapurapu, S. D., Sulaiman, M. K., Kendler, A., Rixe, O., Warnick, R. E., Franco, R. S., & Qi, X. (2014). Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors. Oncotarget. https://doi.org/10.18632/oncotarget.2214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.